Human medicines European public assessment report (EPAR): Kisunla, donanemab, Date of authorisation: 24/09/2025, Revision: 3, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 February 2026 - 12:40

Human medicines European public assessment report (EPAR): Kisunla, donanemab, Date of authorisation: 24/09/2025, Revision: 3, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/kisunla

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters